Associate Professor Chris Milross

Associate Professor
Medicine, Central Clinical School

Telephone +61 2 9515 8746
Fax +61 2 9515 8115

Website Related website

Map

Selected grants

2008

  • Radiobilogical modelling for intensity modualted radiation therapy; Suchowerska N, McKenzie D, Jackson M, Milross C; Cancer Council New South Wales/Research Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Smith, S., Petrak, L., Dhillon, H., Taylor, J., Milross, C. (2014). Are radiation oncologists aware of health literacy among people with cancer treated with radiotherapy? European Journal of Cancer Care, 23(1), 111-120. [More Information]
  • Hong, A., Jones, D., Chatfield, M., Lee, C., Zhang, M., Clark, J., Elliott, M., Harnett, G., Milross, C., Rose, B. (2013). HPV Status of Oropharyngeal Cancer by Combination HPV DNA/p16 Testing: Biological Relevance of Discordant Results. Annals of Surgical Oncology, 20(Suppl 3), S450-S458. [More Information]
  • Hong, A., Martin, A., Armstrong, B., Lee, C., Jones, D., Chatfield, M., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Veness, M., Veivers, D., Rose, B., et al (2013). Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology, 24(1), 215-219. [More Information]
  • Hong, A., Martin, A., Chatfield, M., Jones, D., Zhang, M., Armstrong, B., Lee, C., Harnett, G., Milross, C., Clark, J., Elliott, M., Rose, B., et al (2013). Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. International Journal of Cancer, 132(12), 2748-2754. [More Information]
  • Smith, S., Zhu, Y., Dhillon, H., Milross, C., Taylor, J., Halkett, G., Zilliacus, E. (2013). Supporting patients with low health literacy: what role do radiation therapists play? Supportive Care in Cancer, 21(11), 3051-3061. [More Information]
  • Hong, A., Zhang, M., Veillard, A., Jahanbani, J., Lee, C., Jones, D., Harnett, G., Clark, J., Elliott, M., Milross, C., Rose, B. (2013). The prognostic significance of hypoxia inducing factor 1-alpha in oropharyngeal cancer in relation to human papillomavirus status. Oral Oncology: a journal related to head & neck oncology, 49(4), 354-359. [More Information]
  • Bonner, C., Nattress, K., Anderson, C., Carter, J., Milross, C., Philp, S., Juraskova, I. (2012). Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer. Supportive Care in Cancer, 20(10), 2305-2313. [More Information]
  • Ebrahimi, A., Clark, J., Lorincz, B., Milross, C., Veness, M. (2012). Metastatic head and neck cutaneous squamous cell carcinoma: Defining a low-risk patient. Head and Neck, 34(3), 365-370. [More Information]
  • Varma, R., Carroll, S., Jacobson, I., Milross, C., Post, J. (2011). Combination antiretroviral therapy as treatment for human immunodeficiency virus-associated mucosa-associated lymphoid tissue type lymphoma of the nasopharynx. Internal Medicine Journal, 41(5), 437-438. [More Information]
  • Surjan, Y., Warren-Forward, H., Milross, C. (2011). Is there a role for radiation therapists within veterinary oncology? Radiography, 17(3), 250-253. [More Information]
  • Hong, A., Dobbins, T., Lee, C., Jones, D., Harnett, G., Armstrong, B., Clark, J., Milross, C., Kim, J., O'Brien, C., Rose, B. (2010). Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. British Journal of Cancer, 103, 1510-1517. [More Information]
  • Forest, V., Clark, J., Veness, M., Milross, C. (2010). N1S3: A revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer, 116(5), 1298-1304. [More Information]
  • Hong, A., Grulich, A., Jones, D., Lee, S., Garland, S., Dobbins, T., Clark, J., Harnett, G., Milross, C., O'Brien, C. (2010). Oropharyngeal cancer. Australian data show increase. BMJ (online), 340, c2518. [More Information]
  • Hong, A., Dobbins, T., Lee, C., Jones, D., Jackson, E., Clark, J., Armstrong, B., Harnett, G., Milross, C., O'Brien, C., Rose, B. (2010). Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. European Journal of Cancer, 46(11), 2088-2096. [More Information]
  • Hong, A., Grulich, A., Jones, D., Lee, C., Garland, S., Dobbins, T., Clark, J., Harnett, G., Milross, C., O'Brien, C., Rose, B. (2010). Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine, 28(19), 3269-3272. [More Information]
  • Martin, R., Fulham, M., Shannon, K., Hughes, C., Gao, K., Milross, C., Tin, M., Jackson, M., Clifford, A., Boyer, M., O'Brien, C. (2008). Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. Head and Neck, 31(2), 244-250. [More Information]
  • Bennett, M., Feldmeier, J., Smee, R., Milross, C. (2008). Hyperbaric oxygenation for tumour sensitisation to radiotherapy: A systematic review of randomised controlled trials. Cancer Treatment Reviews, 34(7), 577-591. [More Information]
  • Streit, J., Gao, K., O'Brien, C., Boyer, M., Milross, C. (2007). Hn11p primary chemo-radiotherapy for non-metastatic squamous cell carcinoma of the head and neck. ANZ Journal of Surgery, 77, A39.
  • Zhang, A., Russell, P., Knittel, T., Milross, C. (2007). Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. The Prostate, 67(15), 1630-1640. [More Information]
  • Graham, P., Capp, A., Delaney, G., Goozee, G., Hickey, B., Turner, S., Browne, L., Milross, C., Wirth, A. (2006). A Pilot Randomised Comparison of Dexamethasone 96 mg vs 16 mg per day for Malignant Spinal-cord Compression Treated by Radiotherapy: TROG 01.05 Superdex Study. Clinical Oncology, 18(1), 70-76. [More Information]

2014

  • Smith, S., Petrak, L., Dhillon, H., Taylor, J., Milross, C. (2014). Are radiation oncologists aware of health literacy among people with cancer treated with radiotherapy? European Journal of Cancer Care, 23(1), 111-120. [More Information]

2013

  • Hong, A., Jones, D., Chatfield, M., Lee, C., Zhang, M., Clark, J., Elliott, M., Harnett, G., Milross, C., Rose, B. (2013). HPV Status of Oropharyngeal Cancer by Combination HPV DNA/p16 Testing: Biological Relevance of Discordant Results. Annals of Surgical Oncology, 20(Suppl 3), S450-S458. [More Information]
  • Hong, A., Martin, A., Armstrong, B., Lee, C., Jones, D., Chatfield, M., Zhang, M., Harnett, G., Clark, J., Elliott, M., Milross, C., Veness, M., Veivers, D., Rose, B., et al (2013). Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Annals of Oncology, 24(1), 215-219. [More Information]
  • Hong, A., Martin, A., Chatfield, M., Jones, D., Zhang, M., Armstrong, B., Lee, C., Harnett, G., Milross, C., Clark, J., Elliott, M., Rose, B., et al (2013). Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. International Journal of Cancer, 132(12), 2748-2754. [More Information]
  • Smith, S., Zhu, Y., Dhillon, H., Milross, C., Taylor, J., Halkett, G., Zilliacus, E. (2013). Supporting patients with low health literacy: what role do radiation therapists play? Supportive Care in Cancer, 21(11), 3051-3061. [More Information]
  • Hong, A., Zhang, M., Veillard, A., Jahanbani, J., Lee, C., Jones, D., Harnett, G., Clark, J., Elliott, M., Milross, C., Rose, B. (2013). The prognostic significance of hypoxia inducing factor 1-alpha in oropharyngeal cancer in relation to human papillomavirus status. Oral Oncology: a journal related to head & neck oncology, 49(4), 354-359. [More Information]

2012

  • Bonner, C., Nattress, K., Anderson, C., Carter, J., Milross, C., Philp, S., Juraskova, I. (2012). Chore or priority? Barriers and facilitators affecting dilator use after pelvic radiotherapy for gynaecological cancer. Supportive Care in Cancer, 20(10), 2305-2313. [More Information]
  • Ebrahimi, A., Clark, J., Lorincz, B., Milross, C., Veness, M. (2012). Metastatic head and neck cutaneous squamous cell carcinoma: Defining a low-risk patient. Head and Neck, 34(3), 365-370. [More Information]

2011

  • Varma, R., Carroll, S., Jacobson, I., Milross, C., Post, J. (2011). Combination antiretroviral therapy as treatment for human immunodeficiency virus-associated mucosa-associated lymphoid tissue type lymphoma of the nasopharynx. Internal Medicine Journal, 41(5), 437-438. [More Information]
  • Surjan, Y., Warren-Forward, H., Milross, C. (2011). Is there a role for radiation therapists within veterinary oncology? Radiography, 17(3), 250-253. [More Information]

2010

  • Hong, A., Dobbins, T., Lee, C., Jones, D., Harnett, G., Armstrong, B., Clark, J., Milross, C., Kim, J., O'Brien, C., Rose, B. (2010). Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. British Journal of Cancer, 103, 1510-1517. [More Information]
  • Forest, V., Clark, J., Veness, M., Milross, C. (2010). N1S3: A revised staging system for head and neck cutaneous squamous cell carcinoma with lymph node metastases: results of 2 Australian Cancer Centers. Cancer, 116(5), 1298-1304. [More Information]
  • Hong, A., Grulich, A., Jones, D., Lee, S., Garland, S., Dobbins, T., Clark, J., Harnett, G., Milross, C., O'Brien, C. (2010). Oropharyngeal cancer. Australian data show increase. BMJ (online), 340, c2518. [More Information]
  • Hong, A., Dobbins, T., Lee, C., Jones, D., Jackson, E., Clark, J., Armstrong, B., Harnett, G., Milross, C., O'Brien, C., Rose, B. (2010). Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. European Journal of Cancer, 46(11), 2088-2096. [More Information]
  • Hong, A., Grulich, A., Jones, D., Lee, C., Garland, S., Dobbins, T., Clark, J., Harnett, G., Milross, C., O'Brien, C., Rose, B. (2010). Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine, 28(19), 3269-3272. [More Information]

2008

  • Martin, R., Fulham, M., Shannon, K., Hughes, C., Gao, K., Milross, C., Tin, M., Jackson, M., Clifford, A., Boyer, M., O'Brien, C. (2008). Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. Head and Neck, 31(2), 244-250. [More Information]
  • Bennett, M., Feldmeier, J., Smee, R., Milross, C. (2008). Hyperbaric oxygenation for tumour sensitisation to radiotherapy: A systematic review of randomised controlled trials. Cancer Treatment Reviews, 34(7), 577-591. [More Information]

2007

  • Streit, J., Gao, K., O'Brien, C., Boyer, M., Milross, C. (2007). Hn11p primary chemo-radiotherapy for non-metastatic squamous cell carcinoma of the head and neck. ANZ Journal of Surgery, 77, A39.
  • Zhang, A., Russell, P., Knittel, T., Milross, C. (2007). Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. The Prostate, 67(15), 1630-1640. [More Information]

2006

  • Graham, P., Capp, A., Delaney, G., Goozee, G., Hickey, B., Turner, S., Browne, L., Milross, C., Wirth, A. (2006). A Pilot Randomised Comparison of Dexamethasone 96 mg vs 16 mg per day for Malignant Spinal-cord Compression Treated by Radiotherapy: TROG 01.05 Superdex Study. Clinical Oncology, 18(1), 70-76. [More Information]

To update your profile click here. For support on your academic profile contact .